These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4502575)

  • 1. Sialic acid and bone tumours.
    Brozmanová E; Skrovina B
    Neoplasma; 1972; 19(2):415-24. PubMed ID: 4502575
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical and haematological findings in malignant bone tumours.
    Brozmanová E; SKROVINA B
    Neoplasma; 1974; 21(1):75-82. PubMed ID: 4522900
    [No Abstract]   [Full Text] [Related]  

  • 3. [Value of determination of sialic acid in bone tumors].
    Brozmanová E; Skrovina B
    Acta Chir Orthop Traumatol Cech; 1969 Oct; 36(5):285-91. PubMed ID: 5262632
    [No Abstract]   [Full Text] [Related]  

  • 4. [The behavior of some serum enzyme activities and electrophoretic pattern in patients with osseous neoplasms. Changes after treatment].
    Budroni G; Marogna L; Mundula A
    Arch Sci Med (Torino); 1968 May; 125(5):199-205. PubMed ID: 5246693
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thermographic, radioisotopic and angiographic findings in the diagnosis of malignant primary and metastatic bone neoplasms].
    Ravasini R; Olivotto R; Melanotte PL; Ongaro M; Graziati G; Pistolesi GF
    Quad Radiol; 1968; 33(5):437-53. PubMed ID: 5260828
    [No Abstract]   [Full Text] [Related]  

  • 6. [Malignant, primary bone tumors. Experience report of the Dutch Committee for Bone Tumors].
    von Ronnen JR
    Arch Chir Neerl; 1965; 17(1):23-54. PubMed ID: 5216012
    [No Abstract]   [Full Text] [Related]  

  • 7. The clinical biochemical investigation on the malignant bone tumor. Studies on the variation of serum sialic acid and hexosamine contents in the patients with malignant bone tumor. Preliminary report.
    Nakagawa M; Kajino G; Yoshida T
    Nagoya J Med Sci; 1969 Jul; 32(1):87-102. PubMed ID: 5259739
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diagnosis of tumors and other bone lesions by the trephine biopsy method].
    Sukharev VF; Chistova NM; Aseev LV
    Vopr Onkol; 1970; 16(8):13-20. PubMed ID: 4925811
    [No Abstract]   [Full Text] [Related]  

  • 9. [Problems and experience in the diagnosis of bone tumors].
    Adler CP
    Beitr Pathol; 1972 Jul; 146(4):389-95. PubMed ID: 4560261
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumours of bone and their treatment today.
    Sweetnam R
    Br J Hosp Med; 1980 Nov; 24(5):452, 454, 457-8 passim. PubMed ID: 6934018
    [No Abstract]   [Full Text] [Related]  

  • 11. [Problems of fibrosarcoma of bone and similar diseases].
    Matsuno S; Goto M; Sato Y; Kikuchi S; Yamane S
    Seikei Geka; 1966 Sep; 17(9):675-83. PubMed ID: 5231820
    [No Abstract]   [Full Text] [Related]  

  • 12. Needle biopsy of primary malignant bone tumors.
    Hajdu SI; Melamed MR
    Surg Gynecol Obstet; 1971 Nov; 133(5):829-32. PubMed ID: 4939087
    [No Abstract]   [Full Text] [Related]  

  • 13. Bone case of the month: fibrosarcoma.
    Farrell C; Bourgeois CH
    J Am Med Womens Assoc (1972); 1973 Aug; 28(8):395-7. PubMed ID: 4354202
    [No Abstract]   [Full Text] [Related]  

  • 14. [Malignant bone tumors in the knee region].
    Bumbasirevic Z; Buzdon P
    Beitr Orthop Traumatol; 1984 Feb; 31(2):66-70. PubMed ID: 6586178
    [No Abstract]   [Full Text] [Related]  

  • 15. [Malignant tumors originating in the bone among relatively older patients--cases and keypoints in diagnosis].
    Matsumori S; Fujii M; Kobayashi I; Bando S; Watabe H
    Seikei Geka; 1970 Sep; 21(9):703-10. PubMed ID: 4917806
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical and morphological aspects of malignant bone tumours (author's transl)].
    Adler CP
    Dtsch Med Wochenschr; 1974 Apr; 99(14):655-71. PubMed ID: 4600600
    [No Abstract]   [Full Text] [Related]  

  • 17. Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumors.
    Holzer G; Obermair A; Koschat M; Preyer O; Kotz R; Trieb K
    Med Pediatr Oncol; 2001 Jun; 36(6):601-4. PubMed ID: 11344490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis in osteogenic sarcoma.
    Lockshin MD; Higgins IT
    Clin Orthop Relat Res; 1968; 58():85-103. PubMed ID: 4875296
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum concentrations of sCD30 and sCD40L in patients with malignant bone tumours.
    Holzer G; Pfandlsteiner T; Blahovec H; Trieb K; Kotz R
    Wien Med Wochenschr; 2003; 153(1-2):40-2. PubMed ID: 12621691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary and secondary tumours of the bones].
    Anract P; Tomeno B
    Rev Prat; 2004 Dec; 54(19):2149-60. PubMed ID: 15724594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.